Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. Net Debt
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt | ($96.0M) | ($98.5M) | ($259.3M) | ($566.5M) | ($469.7M) | ($232.3M) | ($512.1M) | ($91.4M) | ($128.8M) | ($577.4M) | ($902.9M) | ($1,314.5M) | ($1,421.8M) | ($2,192.6M) | ($3,856.4M) | ($5,757.2M) | ($4,026.9M) | ($9,113.3M) | ($11.6B) | ($8,141.9M) |
Regeneron Pharmaceuticals, Inc. (REGN) Net Debt comparison analysis
REGN key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Regeneron Pharmaceuticals, Inc.'s Net Debt?
As of today, Regeneron Pharmaceuticals, Inc.'s last 12-month Net Debt is ($7,092.5M), based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Regeneron Pharmaceuticals, Inc.'s Net Debt growth rate?
Over the last year, Regeneron Pharmaceuticals, Inc.'s Net Debt growth was (1.6%). The average annual Net Debt growth rates for Regeneron Pharmaceuticals, Inc. have been 329.8% over the past three years, 26.8% over the past five years.
3) Is Regeneron Pharmaceuticals, Inc.'s Net Debt growth rate Good?
Over the last year, Regeneron Pharmaceuticals, Inc.'s Net Debt growth was (1.6%), which is lower than industry growth of (0.1%). It indicates that Regeneron Pharmaceuticals, Inc.'s Net Debt growth is Good.